Marine Biologics
Marine Biologics develops macroalgae-based clean-label ingredient systems for food and beverage manufacturers. Its flagship SeaTex seaweed powder replaces multi-ingredient gum stacks, powered by the proprietary MacroLink AI engine for ingredient discovery.
- Company typePrivate
- Founded2024
- HeadquartersBerkeley, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Marine Biologics does
Marine Biologics is a California-based startup founded in 2024 that manufactures macroalgae-based ingredient systems for the food and beverage industry. Its flagship commercial product, SeaTex, is a brown seaweed-derived powder that stabilizes proteins and binds fats in formulations, replacing multi-ingredient gum stacks (fibers, minerals, bioactives, emulsifiers, buffers) with a single clean-label ingredient. The company's underlying technology is the MacroLink AI engine, a cheminformatics-driven discovery platform paired with standardized seaweed feedstock the company calls SuperCrudes, which the firm claims compresses ingredient development timelines from years to months. SeaTex holds FDA GRAS designation and has been validated for UHT, HTST, and retort processing, with documented results of reducing ready-to-drink coffee formulations from nine ingredients (four additives) to six ingredients (zero additives).
The company operates a sales-led B2B go-to-market, engaging directly with food and beverage manufacturers and formulation teams through website contact, industry event participation (notably Future Food-Tech in San Francisco), and partnership discussions. Initial commercial focus spans ready-to-drink beverages, dairy alternatives, and baking applications. Revenue is generated through direct ingredient sales, though pricing is not publicly disclosed and no customers are named in available sources. The company acquired Spoitz Enterprises in November 2024, has been recognized as a Top Food Technology Company for 2025 by the FoodNavigator Global Food Tech Awards, and is led by Patrick Griffin (CEO), Danièle Karleskind (COO/CXO), and Ryan Hunt (Director of Business Development). Marine Biologics is privately held, headquartered in Berkeley, California, has 1-10 employees, and has no disclosed funding rounds or revenue figures in the available source material.
Marine Biologics firmographics
Firmographics- Name
- Marine Biologics
- Legal name
- Marine Biologics, Inc.
- Website
- https://marinebiologics.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Marine Biologics develops macroalgae-based clean-label ingredient systems for food and beverage manufacturers. Its flagship SeaTex seaweed powder replaces multi-ingredient gum stacks, powered by the proprietary MacroLink AI engine for ingredient discovery.
- Ownership category
- akta.pro rank
Marine Biologics industry classification
Industry- Product category
- Food Ingredients
- NAICS
- Fruit and Vegetable Preserving and Specialty Food Manufacturing (3114)
- SIC
- Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Seaweed Hydrocolloids (Agar, Carrageenan, Alginates) (AFAJAMAD)
- akta.pro secondary industry
- Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)
Keywords
Where Marine Biologics is headquartered
LocationHeadquarters
- HQ city
- Berkeley
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Marine Biologics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales
Revenue model
- SeaTex Ingredient Sales: B2B ingredient sales to food and beverage manufacturers. Revenue generated through direct product sales of SeaTex seaweed powder ingredient for use in formulations including RTD beverages, dairy alternatives, and baking applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Marine Biologics product offering
Product offeringCore offering
Marine Biologics manufactures macroalgae-based ingredient systems for the food and beverage industry, with SeaTex, a seaweed powder ingredient that stabilizes proteins and binds fats, as its flagship product. The company also operates MacroLink, an AI-powered engine using cheminformatics to design new functional food ingredients from seaweed-derived biological materials (SuperCrudes), compressing ingredient discovery from years to months.
Product overview
Marine Biologics is a California-based startup that offers a platform approach to clean-label ingredient discovery. The core offering consists of SeaTex (a seaweed powder ingredient) and MacroLink (an AI-powered ingredient design engine). MacroLink uses AI and cheminformatics to analyze seaweed-derived materials (called SuperCrudes) to develop functional ingredients, while SeaTex is the commercial product resulting from this technology—a protein stabilizer and suspension system that replaces multiple additives with a single clean-label ingredient.
Differentiator
Problem solved
Functional benefit
Products and services
- SeaTex Seaweed powder ingredient sourced from brown seaweed that stabilizes proteins and binds fats in food and beverage formulations. One ingredient replaces 3-5 gums and buffers, reducing label complexity (e.g., 9 to 6 ingredients in RTD coffee formulations) and eliminating four additives. Validated for UHT, HTST, and retort processing and holds FDA GRAS designation. Sold to food and beverage manufacturers.
- MacroLink AI Ingredient Design Engine AI-powered ingredient design platform that uses artificial intelligence and cheminformatics to convert seaweed-derived biological resources (SuperCrudes) into scalable food ingredients, compressing discovery timelines from years to months. Underpins Marine Biologics' ingredient development pipeline.
Quantifiable outcome
- Reduces formulation ingredients from 9 to 6 in RTD coffee applications
- +2 more outcomes
Companies that use Marine Biologics
Customer profileSegments2 records
Ideal customer profiles2 records
Marine Biologics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
Marine Biologics partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Marine Biologics competitors and assessment
Company assessmentDirect peers
- Algaia: French specialty seaweed ingredient company producing alginates, carrageenans, and customized seaweed extracts for food, personal care, and nutrition applications. Closest direct peer to Marine Biologics given its seaweed-derived functional food ingredient focus.
- CP Kelco (IFF): Leading global manufacturer of hydrocolloids including carrageenan, pectin, gellan gum, and xanthan gum used for protein stabilization and texture in food and beverages. Direct competitor to SeaTex in seaweed-derived texturizer systems.
- Acadian Seaplants: Nova Scotia-based marine plant processor extracting ingredients from seaweed (Ascophyllum nodosum, etc.) for agricultural, food, and personal care applications. Direct peer with comparable seaweed-based ingredient platform.
Broad incumbents
- Tate & Lyle: Global food ingredient supplier with a strong clean-label portfolio (e.g., tapioca-based starches replacing modified starches). Direct overlap with Marine Biologics' clean-label positioning for protein stabilization and texture.
- Ingredion: Major ingredient supplier offering clean-label starches, fibers, and texturizers (e.g., HOMECRAFT, VERITY lines) to food and beverage manufacturers. Comparable broad clean-label reformulation solutions for CPG customers.
- Kerry Group: Global taste and nutrition company supplying clean-label ingredients, proteins, and functional systems to food and beverage manufacturers. Overlaps with Marine Biologics in beverage and dairy alternative formulation support.
- Cargill: One of the world's largest agricultural and food ingredient companies, supplying starches, proteins, texturizers, and seaweed-derived ingredients across CPG applications. Broad incumbent competing for the same clean-label shelf space as Marine Biologics.
- DuPont Nutrition & Biosciences (IFF): Through its integration with IFF, supplies a wide portfolio of food ingredients including hydrocolloids, cultures, enzymes, and soy proteins. Comparable incumbent selling functional ingredients to large CPG customers.
- Corbion: Global ingredient supplier specializing in food preservation, lactic acid, and functional ingredients for bakery, beverage, and dairy. Comparable as a broad incumbent in food ingredient systems serving CPG customers.
- ADM: Major food ingredient and agricultural processor supplying proteins, flavors, colors, and texturizing solutions globally. Overlaps with Marine Biologics as a broad incumbent serving F&B manufacturers with functional ingredient portfolios.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Marine Biologics social profiles
Digital presenceMarine Biologics compliance and trust
Trust signalCompliance1 record
Marine Biologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Marine Biologics leadership team
Management profileNumber of profiles
Profiles3 records
Marine Biologics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Marine Biologics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Marine Biologics
What does Marine Biologics do?
Marine Biologics manufactures macroalgae-based ingredient systems for the food and beverage industry, with SeaTex, a seaweed powder ingredient that stabilizes proteins and binds fats, as its flagship product. The company also operates MacroLink, an AI-powered engine using cheminformatics to design new functional food ingredients from seaweed-derived biological materials (SuperCrudes), compressing ingredient discovery from years to months.
Is Marine Biologics a public or private company?
Marine Biologics is a private company. It is classified as unknown and is currently operating.
When was Marine Biologics founded?
Marine Biologics was founded in 2024. It employs 11 to 50 people.
Where is Marine Biologics based?
Marine Biologics is headquartered in Berkeley, United States, in the North America region.
How does Marine Biologics make money?
One revenue line is on record: seaTex Ingredient Sales.
Who are Marine Biologics's main competitors?
Direct peers on record are Algaia, CP Kelco (IFF) and Acadian Seaplants. Broad incumbents are Tate & Lyle, Ingredion, Kerry Group, Cargill, DuPont Nutrition & Biosciences (IFF), Corbion and ADM.
Does Marine Biologics have an API?
No public API is recorded for Marine Biologics.
What industry is Marine Biologics in?
Marine Biologics's product category is Food Ingredients. Its primary akta.pro industry code is AFAJAMAD, Seaweed Hydrocolloids (Agar, Carrageenan, Alginates), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae). Its NAICS code is 3114 and its SIC code is 2090.